Brown, Lisle/Cummings’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.8K Hold
4,143
0.01% 444
2025
Q4
$29.7K Sell
4,143
-718
-15% -$5.67K 0.01% 396
2025
Q3
$51.9K Sell
4,861
-120
-2% -$1.18K 0.01% 338
2025
Q2
$48.2K Sell
4,981
-1,544
-24% -$15.9K 0.01% 339
2025
Q1
$97.2K Sell
6,525
-400
-6% -$6.15K 0.03% 275
2024
Q4
$103K Sell
6,925
-1,768
-20% -$28.8K 0.03% 265
2024
Q3
$166K Sell
8,693
-1,629
-16% -$33.8K 0.05% 222
2024
Q2
$214K Sell
10,322
-2,297
-18% -$45.6K 0.07% 192
2024
Q1
$237K Sell
12,619
-2,003
-14% -$34.4K 0.08% 181
2023
Q4
$211K Sell
14,622
-8,312
-36% -$113K 0.08% 191
2023
Q3
$398K Sell
22,934
-1,115
-5% -$23.3K 0.18% 119
2023
Q2
$500K Sell
24,049
-2,569
-10% -$55.8K 0.22% 104
2023
Q1
$626K Sell
26,618
-1,091
-4% -$29.3K 0.32% 77
2022
Q4
$774K Sell
27,709
-533
-2% -$13.6K 0.42% 56
2022
Q3
$661K Hold
28,242
0.39% 64
2022
Q2
$953K Buy
28,242
+1,581
+6% +$55.4K 0.53% 47
2022
Q1
$931K Buy
26,661
+3,035
+13% +$104K 0.45% 57
2021
Q4
$719K Buy
+23,626
New +$770K 0.36% 67

Other funds holding OGN

Brown, Lisle/Cummings's OGN Position: Q1 2026 in Review

Brown, Lisle/Cummings held its Organon & Co (OGN) position steady in Q1 2026 at 4,143 shares worth $24.8K. The position accounts for 0.01% of the portfolio, ranked #444.

Brown, Lisle/Cummings first reported a position in OGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $953K in Q2 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Brown, Lisle/Cummings held 4,143 shares of Organon & Co worth $24.8K as of Q1 2026.
  • Brown, Lisle/Cummings left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up 0.01% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #444 holding.
  • Brown, Lisle/Cummings first reported a position in Organon & Co in Q4 2021 and has held it in 18 quarters since.
  • Brown, Lisle/Cummings's Organon & Co position peaked at $953K in Q2 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.